NCT06316739Active, not recruiting
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City
Ending HIV and Taming Hepatitis C Virus and Overdose Among Puerto Rican People Who Inject Drugs in New York City: The Ganchero Intervention
Source: ClinicalTrials.gov · Last updated 24 Jul 2026
Brief summary (registry, in English)
The goal of this pilot clinical trial is to learn if an intervention that trains Gancheros (people who provide injection services in exchange for drugs or money) to conduct risk-reduction outreach could help lower risk for human immunodeficiency virus (HIV), hepatitis C virus (HCV) and overdose among migrant Puerto Rican people who inject drugs (PWID) in New York City. The main questions it aims to answer are: * Can the Ganchero intervention be carried out successfully and will Gancheros and their clients like it? * Could the Ganchero intervention help Puerto Rican PWID who are clients of Gancheros use sterile syringes and carry naloxone (a medication to reverse opioid overdoses) more often? Gancheros who participate in the trial will be asked to attend a 6-session training on HIV, HCV, and overdose prevention and then to share key prevention messages and supplies (e.g., naloxone, sterile syringes and other injection equipment) with their clients during 4 months of outreach. The intervention will be carried out with Gancheros and their clients in two Bronx neighborhoods, one after the other, so the investigators can see if clients in the neighborhood that received the intervention first have better outcomes than clients in the neighborhood that did not yet receive the intervention.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 69 (actual)
- First submitted
- 27 Feb 2024
- Start date
- 1 May 2024
- Primary completion date
- 1 Nov 2027
- Lead sponsor
- North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI)
- Diseases
- HIV
- NCT number
- NCT06316739
What you commit to
- Study type: Interventional
- Participants enrolled: 69
- From 1 May 2024 to the primary completion date, 1 Nov 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Two distinct groups of participants with different eligibility criteria will be enrolled: (1) Gancheros (n=10, 5/neighborhood); and (2) Gancheros' clients (n=60, 30/neighborhood).
- Ganchero participants:
- Inclusion Criteria:
- A migrant person who injects drugs (PWID) from Puerto Rico living in one of 2 pre-selected neighborhoods in the Bronx, New York City (NYC)
- Past experience providing Ganchero services in Puerto Rico
- Currently provides Ganchero services to ≥10 clients/day
- Speaks Spanish or English
- Exclusion Criteria:
- Planned travel away from NYC for 2 weeks or longer over the next 24 months
- Inability to comprehend trial information or provide informed consent (e.g., due to intoxication)
- Client participants:
- Inclusion Criteria:
- A migrant PWID from Puerto Rico living in one of 2 pre-selected neighborhoods in the Bronx, NYC
- Referred to the study by a participating Ganchero
- Used the services of their nominating Ganchero at least once/week for the past 90 days
- Speaks Spanish or English
- Exclusion Criteria:
- Inability to comprehend trial information or provide informed consent (e.g., due to intoxication)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CUNY Graduate School of Public Health & Health Policy Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.